GLORIA

GEOMAR Library Ocean Research Information Access

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • Future Medicine Ltd  (2)
Materialart
Verlag/Herausgeber
  • Future Medicine Ltd  (2)
Sprache
Erscheinungszeitraum
  • 1
    Online-Ressource
    Online-Ressource
    Future Medicine Ltd ; 2014
    In:  Immunotherapy Vol. 6, No. 2 ( 2014-02), p. 155-164
    In: Immunotherapy, Future Medicine Ltd, Vol. 6, No. 2 ( 2014-02), p. 155-164
    Kurzfassung: Type 1 diabetes (T1D) is an immune-mediated disease that occurs when the insulin-producing β‑cells of the pancreatic islets are destroyed by an inflammatory process perpetuated by cells of the immune system. The logical approach to suppress T1D is to inactivate or eliminate the lymphocytes responsible for inducing inflammation and targeting the β‑cells. Antigen-specific approaches have been devised and were able to target inflammatory lymphocytes and induce apoptosis or block trafficking to pancreatic islets. Lack of costimulation, expansion of Tregs and bystander suppression are likely mechanisms by which antigen-specific treatments modulate pathogenic T cells. This strategy, however, while prevents the onset of T1D, could not overcome overt T1D, perhaps because of collateral damage to the islet vascular network. Recent developments indicate that donor endothelial stem cell precursors can repair the islets’ vascular niche and assist antigen-specific therapy against overt T1D.
    Materialart: Online-Ressource
    ISSN: 1750-743X , 1750-7448
    Sprache: Englisch
    Verlag: Future Medicine Ltd
    Publikationsdatum: 2014
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    Online-Ressource
    Online-Ressource
    Future Medicine Ltd ; 2009
    In:  Immunotherapy Vol. 1, No. 1 ( 2009-01), p. 27-29
    In: Immunotherapy, Future Medicine Ltd, Vol. 1, No. 1 ( 2009-01), p. 27-29
    Kurzfassung: Evaluation of: Yang XO, Nurieva R, Martinez GJ et al.: Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44–57 (2008). The insight gained recently on the differentiation of naive CD4 T cells challenges the dogma that expression of canonical transcription factors and production of signature cytokines portray a commitment to a specific lineage and a point of no return. For almost two decades now, the belief has been that naive CD4 T cells, under the guidance of environmental signals, follow a one-way road to evolve as Th1, Th2, Th17 or regulatory T cells (Tregs). The current paper, however, demonstrates a crosstalk between signals and identifies transitory T-cell states whereby a differentiating CD4 + T cell will express a mixed Th17 and Treg phenotype. Moreover, they were able to successfully reprogram terminally differentiated Tregs into Th17 cells, suggesting that redifferentiation could occur and provides an environmental plasticity to readjust immunity. This suggests that T-cell differentiation does not necessarily follow a one-way road, but that traffic may flow in both directions.
    Materialart: Online-Ressource
    ISSN: 1750-743X , 1750-7448
    Sprache: Englisch
    Verlag: Future Medicine Ltd
    Publikationsdatum: 2009
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...